Comparing Alpelisib vs Ribociclib
| Alpelisib | Ribociclib |
|
|---|
| Alpelisib | Ribociclib |
|
|---|---|---|
|
Prescription only
Prescribed for PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Breast Cancer - Male. Alpelisib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Breast Cancer - Metastatic, Breast Cancer. Ribociclib may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
|
| More about Alpelisib | More about Ribociclib | |
| Ratings & Reviews | ||
|
Alpelisib has an average rating of 7.4 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
Ribociclib has an average rating of 8.2 out of 10 from a total of 40 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 8% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Alpelisib side effects |
View all Ribociclib side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Piqray, Vijoice | Kisqali | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
9 hours |
54.7 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 340 drugs are known to interact with Alpelisib:
|
A total of 747 drugs are known to interact with Ribociclib:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
May 24, 2019 |
N/A |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Piqray
Piqray (alpelisib) is used to treat breast cancer that has a PIK3CA gene mutation. Piqray is a ...
Vijoice
Vijoice (alpelisib) is used to treat severe PIK3CA-Related Overgrowth Spectrum (PROS). Includes ...
Letrozole
Letrozole is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic, female ...
Tamoxifen
Tamoxifen blocks the actions of estrogen and is used to treat and prevent some types of breast ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.